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Myoclonus-dystonia (M-D) is an autosomal dominant disorder characterized by myoclonic and dystonic muscle
contractions that are often responsive to alcohol. The dopamine D2 receptor gene (DRD2) on chromosome 11q
has been implicated in one family with this syndrome, and linkage to a 28-cM region on 7q has been reported in
another. We performed genetic studies, using eight additional families with M-D, to assess these two loci. No
evidence for linkage was found for 11q markers. However, all eight of these families showed linkage to chromosome
7 markers, with a combined multipoint LOD score of 11.71. Recombination events in the families define the disease
gene within a 14-cM interval flanked by D7S2212 and D7S821. These data provide evidence for a major locus
for M-D on chromosome 7q21.
Myoclonus-dystonia (M-D), previously known as “idio-
pathic hereditary myoclonus,” “hereditary essential my-
oclonus,” or “myoclonic dystonia” (Lang 1997 [MIM
159900]), is a rare movement disorder that is transmit-
ted as an autosomal dominant trait with reduced pen-
etrance. M-D usually starts in childhood or adolescence
and is characterized clinically by involuntary lightning
jerks (myoclonus) that respond dramatically to alcohol
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and by dystonia, frequently involving the neck and arms
(Mahloudji and Pikielny 1967; Quinn 1996; Gasser
1998). Because of the prominence of both myoclonus
and dystonia, M-D has been grouped under the “dys-
tonia plus” category (Fahn et al. 1998), thus differen-
tiating it from early-onset generalized dystonia (DYT1)
and other primary dystonias.
Previously, it was reported that a missense change
(Val154Ile) in a conserved region of the D2 dopamine
receptor (DRD2) on chromosome 11q23 cosegregated
with M-D in one large family (Klein et al. 1999). How-
ever, sequence analysis of the DRD2 gene in 17 M-D
patients from other families and linkage analysis using
chromosome 11 markers surrounding this gene in an-
other four clinically similar families were negative, sug-
gesting locus heterogeneity for this disorder (Durr et al.
2000; Klein et al. 2000). This idea was confirmed when
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Figure 1 Pedigrees of families not described elsewhere in which M-D is linked to chromosome 7. An asterisk (*) denotes DNA samples,
and slashes denote deceased individuals.
a second M-D locus was mapped to a 28-cM region on
chromosome 7q21-q31 in a single family (Nygaard et
al. 1999).
In the present study, we evaluated eight families (A–H)
with M-D for linkage to the known M-D loci. In ad-
dition, two candidate genes (GNG11 and GNGT1) in
the chromosome 7q region were screened for mutations.
The various local IRBs approved these studies. After
giving informed consent, 107 members of eight families
with M-D underwent neurological examination by
movement disorders specialists. Secondary myoclonus
and dystonia were excluded by both history and lack of
additional neurological signs in all cases and by brain
imaging in selected cases. Index patients were videotaped
and the tapes were reviewed by a member of the clinical
team (S.B.B.) masked to pedigree and genotype status.
The diagnoses of dystonia and myoclonus were estab-
lished according to published criteria (Mahloudji and
Pikielny 1967; Bressman et al. 1989; Quinn 1996).
Forty-two individuals were diagnosed with M-D (num-
ber of affected individuals with DNA sample, family A:
4; family B: 2; family C: 3; family D: 2; family E: 7;
family F: 3; family G: 3; and family H: 18). The phe-
notype in these eight families is consistent with the phe-
notype of the families described elsewhere (Klein et al.
1999; Nygaard et al. 1999). The mean age at onset was
years (range 1–37 years). Both the myoclonus8.1 5.9
and the dystonia, whether present individually or to-
gether, were most prominent in the neck and arm; other
sites involved included the trunk and face. Seven of the
families had at least one affected family member with
known response to alcohol. Detailed clinical findings,
including pedigrees, for the following families have been
described elsewhere: families A and D (Klein et al. 2000),
family E (Kurlan et al. 1988), and family H (Kyllerman
et al. 1990). Pedigrees of the families not described else-
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Table 1
Two-Point LOD Scores for Chromosome 7 Markers in M-D Families
MARKER
(LOCATION)
AND FAMILYa
Z AT v p
.00 .01 .05 .10 .20 .30
D7S2204 (90.95):
A .00 .00 .00 .00 .00 .00
B ND
C ND
D .25 .25 .22 .18 .11 .05
E 2.21 2.03 1.14 .66 .25 .09
F ND
G 2.56 1.11 .48 .25 .08 .03
H ND
Total 4.52 2.89 1.40 .73 .22 .07
D7S2212 (95.43):
A .00 .00 .00 .00 .00 .00
B .00 .00 .00 .00 .00 .00
C .55 .53 .47 .39 .24 .12
D .19 .18 .14 .10 .04 .01
E 1.88 .20 .38 .54 .53 .37
F .47 .45 .38 .30 .17 .07
G .73 .71 .62 .52 .34 .18
H 3.86 3.79 3.49 3.09 2.28 1.44
Total 3.92 5.46 5.48 4.94 3.60 2.19
D7S2410 (100.81):
A .60 .59 .54 .47 .32 .17
B .00 .00 .00 .00 .00 .00
C .57 .55 .48 .40 .25 .12
D .26 .25 .22 .18 .11 .05
E .30 .30 .28 .26 .21 .15
F .90 .88 .79 .68 .45 .23
G .70 .68 .60 .50 .32 .17
H 4.84 4.75 4.39 3.93 2.94 1.88
Total 8.17 8.00 7.30 6.42 4.60 2.77
D7S646 (104.86):
A .60 .59 .54 .47 .32 .17
B .00 .00 .00 .00 .00 .00
C .31 .30 .26 .22 .14 .07
D .22 .21 .17 .12 .05 .01
E 1.82 1.79 1.66 1.49 1.13 .73
F .78 .76 .69 .59 .39 .20
G .70 .68 .60 .50 .32 .17
H 4.53 4.44 4.09 3.64 2.67 1.63
Total 8.96 8.77 8.01 7.03 5.02 2.98
D7S657 (104.86):
A .00 .00 .00 .00 .00 .00
B .00 .00 .00 .00 .00 .00
C .15 .14 .12 .10 .06 .03
D .22 .21 .17 .12 .05 .01
E 1.82 1.79 1.66 1.49 1.13 .73
F .49 .47 .40 .32 .18 .07
G .80 .78 .69 .58 .38 .20
H 5.17 5.08 4.71 4.24 3.22 2.11
Total 8.65 8.47 7.75 6.85 5.02 3.15
(continued)
MARKER
(LOCATION)
AND FAMILYa
Z AT v p
.00 .01 .05 .10 .20 .30
D7S1820 (105.92):
A .60 .59 .54 .47 .32 .17
B .00 .00 .00 .00 .00 .00
C .56 .54 .48 .39 .24 .11
D .00 .00 .00 .00 .00 .00
E .31 .30 .28 .26 .21 .15
F .17 .17 .14 .11 .06 .03
G .63 .61 .53 .44 .28 .14
H 3.93 3.87 3.59 3.22 2.41 1.56
Total 6.20 6.08 5.56 4.89 3.52 2.16
D7S2482 (108.59):
A .60 .59 .54 .47 .32 .17
B ND
C .57 .55 .48 .40 .25 .12
D ND
E 1.20 1.18 1.09 .98 .72 .43
F .22 .21 .18 .14 .07 .03
G .83 .81 .72 .61 .40 .22
H .86 .84 .78 .69 .52 .35
Total 4.28 4.18 3.79 3.29 2.28 1.32
D7S821 (109.12):
A .00 .00 .00 .00 .00 .00
B ND
C .57 .55 .48 .40 .25 .12
D .21 .21 .17 .12 .05 .01
E 1.82 1.79 1.66 1.49 1.13 .73
F .61 .60 .54 .47 .32 .17
G 2.73 1.03 .41 .19 .05 .02
H 3.06 3.00 2.75 2.42 1.74 1.05
Total 3.54 5.12 5.19 4.71 3.44 2.06
D7S1799 (113.92):
A 3.00 1.39 .72 .44 .19 .08
B .30 .29 .26 .22 .13 .06
C ND
D .23 .22 .18 .13 .05 .01
E ND
F ND
G .68 .66 .58 .48 .30 .16
H 2.36 .65 1.74 1.96 1.75 1.24
Total 4.15 .43 2.04 2.35 2.04 1.47
NOTE. ND p not done.
a Map locations are based on a combination of the Marshfield Med-
ical Research Foundation map and the Genetic Location Database.
where (families B, C, F, and G) are shown in figure 1.
The mode of transmission was consistent with autoso-
mal dominant inheritance with reduced penetrance in all
eight families.
DNA was extracted from venous blood samples and
genotyping was performed according to a standard PCR
protocol (Research Genetics), using a LICOR automated
sequencer. The following markers were used on chro-
mosome 7: D7S2204 – 4.48 cM – D7S2212 – 5.38 cM
– D7S2410 – 4.05 cM – D7S646 – 0.0 cM – D7S657
– 1.06 cM – D7S1820 – 2.67 cM – D7S2482 – 0.53
cM – D7S821 – 4.80 cM – D7S1799. The following
markers were used on chromosome 11: D11S2000 –
3.98 cM – D11S1391 – 0.57 cM – D11S897 – 0.00 cM
– D11S1986 (DRD2 is located between D11S1391 and
D11S897/1986). Map order was obtained from the Ge-
netic Location Database, and distances are based on the
Marshfield Medical Research Foundation database.
We conducted two-point and multipoint linkage anal-
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Figure 2 Multipoint LOD scores for all eight families. Markers used and their map positions are listed on the X-axis. Zmax is 11.71 at
marker D7S646, although most of the region between D7S2212 and D7S821 reveals a LOD score 110.
Table 2
Primer Pairs for Exon Amplification of GNGT1 and GNG11
GENE
AND EXON
PRIMER (5′r3′)
Forward Reverse
GNGT1:
Exon 1 CTCCAGCAATTCATGCATAG ACTCCCACAGTATCTCTAGC
Exon 2 CTGGCATCTGGAGTATTCTG CACGTACATGCTTAGTAGTA
GNG11:
Exon 1 GCCTTCAGTTGTTTCGGGA CAGGAAAAATCGGACCCTGC
Exon 2 CATTAAGGCGTAGGGACAAAG AGTGAGCAAAGATGAGTAGC
yses, using the VITESSE program (O’Connell and Weeks
1995) and assuming autosomal dominant inheritance of
a rare allele (frequency .0001) with reduced penetrance.
Since reliable estimates of penetrance are not available
for this disorder, we used an “affecteds-only” model in
which only those with features of definite myoclonus,
definite dystonia, or both were considered affected. All
others were coded as “unknown” for disease status, and
penetrance was assumed to be very low (1%). Marker
allele frequencies were assumed to be equal. Two-point
LOD scores were calculated for both chromosome 7 and
chromosome 11 markers within the two M-D regions.
No positive linkage to the region of DRD2 (chro-
mosome 11q) could be demonstrated in any of these
eight families (data not shown; Klein et al. 2000). How-
ever, chromosome 7 markers were consistent with link-
age in all eight families (table 1), with the maximum
combined two-point LOD score (Zmax) at D7S646
( at recombination fraction [v] 0.0). Five mark-Zp 8.96
ers that span the region, including D7S2212, D7S2410,
D7S646, D7S1820, and D7S821, were used in a mul-
tipoint linkage analysis. Results are presented in figure
2 and show a maximum combined multipoint LOD
score of 11.71 at D7S646. Critical crossover events that
define the gene location occurred in an affected individ-
ual (family G, individual 416) and an obligate gene car-
rier (family E, individual 416) and are shown along with
other key individuals in figure 3. Specifically, there are
crossovers between D7S2212 and D7S64 in family E
(D7S2410 is uninformative) and between D7S2482 and
D7S821 in family G. This narrows the candidate region
to a 14-cM interval between D7S2212 and D7S821 and
substantially reduces the initially reported region of 28
cM (Nygaard et al. 1999). There was no shared (partial)
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Figure 3 Partial pedigrees for the families possessing critical recombination events. The shaded chromosomes are the disease-bearing
chromosomes. In family E, individual 416 has a crossover between D7S2212 and D7S646, with D7S2410 being uninformative. In family G,
individual 416 has a recombination between D7S821 and D7S1820. Taken together, these crossovers place the M-D locus between D7S2212
and D7S821, an interval of ∼14 cM. The distances between markers are given in the text.
haplotype within the linked region across families, ren-
dering a recent common founder mutation unlikely.
Large parts of the chromosome 7q region have already
been sequenced and well characterized (Bouffard et al.
1997), thereby facilitating the search for candidate genes.
On the basis of the apparent involvement of DRD2 in
one family with M-D, the two gamma subunits of guanine
nucleotide-binding proteins (G-proteins GNG11 and
GNGT1) that are located in this region of chromosome
7 (National Center for Biotechnology Information acces-
sion number AC002076) represented appealing candi-
dates for mutation screening. G proteins are involved as
modulators or transducers in various transmembrane sig-
naling systems and thus could interact with the dopamine
D2 receptor in second messenger pathways.
We designed primer pairs to allow bidirectional se-
quencing of the two exons of each gene (table 2). Ge-
nomic DNA from one affected member of each family
or from control individuals was amplified using standard
PCR conditions. Dideoxy cycle sequencing of PCR prod-
ucts was performed with the Thermo Sequenase Fluor
Primer Cycle Sequencing Kit (Amersham). No mutations
were found in the coding regions of these two genes in
any of the families. However, in GNGT1, a GrA tran-
sition at base pair 148 (E50K) was detected in families
E, H, and C. When other affected members of these
families were typed, this change was not inherited with
the disease. In addition, this same variation was seen in
control individuals. Both of these findings suggest that
the E50K change is a polymorphism. Previously, Ny-
gaard et al. (1999) excluded sequence alterations in the
gene for the human metabotropic glutamate receptor
type 3 (GRM3) in another family with M-D linked to
7q. Since the candidate region is still quite large and
contains many genes, linkage studies, currently in pro-
gress, of additional families with M-D and identification
of more markers in the region will be needed for further
fine mapping of this locus.
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